BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medilink Midlands
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20241120T100000
DTEND;TZID=Europe/London:20241120T163000
DTSTAMP:20260408T005256
CREATED:20241009T113940Z
LAST-MODIFIED:20241121T145930Z
UID:32965-1732096800-1732120200@staging.medilinkmidlands.com
SUMMARY:IN PERSON Event: Innovations Against AMR 2024
DESCRIPTION:We are pleased to announce the 3rd Annual Innovations Against AMR event\, taking place place on Wednesday 20th November at Enterprise Wharf in Birmingham. \nThe event is running during World Antimicrobial Resistance Awareness Week (WAAW)\, a global campaign to raise awareness of antimicrobial resistance and encourage best practices to prevent the spread of drug-resistant infections. The Theme for WAAW 2024 is “Educate. Advocate. Act now”.   \nThis year\, our Innovations Against AMR Event is focused on novel developments within the field of combating AMR throughout the UK\, with a special focus on small and medium enterprises. We are interested in hearing from companies in various stages of spinning out and developing their ideas and providing a platform for discussion\, collaborations and advocacy against AMR.   \nThis event has grown year on year\, bringing together innovators\, researchers and other stakeholders working in this sector and has proven a great opportunity for networking and building collaborations. Medilink Midlands are pleased to be partnering with WMHTIA\,  Bruntwood\, Cytecom and the newly established UKRI AMR Network – ARREST AMR to deliver this event:  \n\nWMHTIA provides companies access to services and expertise that are essential in critically developing technologies. \n\n\nMedilink Midlands provides support services to healthcare businesses in the Midlands region\, including networking opportunities\, business development advice\, and access to funding. \n\n\nBruntwood SciTech is a property and innovation company that provides flexible workspace and support services to science and technology businesses. \n\n\nCytecom is a pioneering SME that has developed a rapid method for diagnosing bacterial infections and advocates for raising awareness about antimicrobial resistance.  \n\n\nThe ARREST-AMR (Accurate\, Rapid\, Robust\, and Economical One Health Diagnostics for antimicrobial resistance) network will work alongside seven other networks to bring together diverse expertise from academia\, industry\, government\, regulatory agencies\, and charities. They will foster collaborations\, drive innovation\, and develop effective strategies for implementing fit-for-purpose One Health AMR Diagnostics. \n\n  \n5 Reasons to Attend the 3rd Annual Innovations Against AMR Event\n1. Be at the forefront of AMR innovation: Connect with leading innovators\, researchers\, and industry experts driving advancements in combating antimicrobial resistance. Discover the latest breakthroughs and explore potential collaborations. \n2. Support SMEs and foster growth: Learn about innovative solutions developed by small and medium enterprises (SMEs) and contribute to their success. Network with like-minded individuals to create new partnerships and drive innovation. \n3. Gain valuable insights and knowledge: Attend engaging presentations and discussions on the latest trends and challenges in the field of AMR. Expand your understanding of the issue and stay ahead of the curve. \n4. Network with key stakeholders: Connect with representatives from organisations like Medilink Midlands\, WMHTIA\, Bruntwood\, Cytecom\, and the ARREST-AMR network. Build relationships and explore potential partnerships. \n5. Contribute to a global cause: Join the fight against antimicrobial resistance by attending this event. Be part of a community dedicated to raising awareness\, promoting best practices\, and driving positive change. \n  \nAgenda\n10:00am    Registration \n10:30am    Opening Remarks \n10:50am    Session 1: Understanding and Tackling the Multidimensional Challenges of AMR \n11:05am     Arrest AMR Network Introduction \n11:35am     Role of AMR Diagnostics in Primary Care \n11:50am     Comfort break \n12pm          Showcase of Innovators \n12:30pm    Lunch break \n1:15pm       Session 2: From Concept to Commercial \n2:15pm      Showcase of Innovators \n2:45pm      National Biofilm Innovation Centre \n3:15pm      Closing Remarks followed by networking \n4:30pm     Depart \n  \nSpeaker Information\n \nDr Enrico Marsili \nDr Enrico Marsili received his PhD in Chemical Engineering from the University of Rome\, Italy. After postdoctoral research at University of Minnesota\, he took a Lecturer position at Dublin City University. In 2012\, he joined the newly formed Singapore Centre for Environmental Life Sciences Engineering\, Singapore\, as Principal Scientist. In 2019\, he moved to Nazarbayev University as Associate Professor in the Department of Chemical and Materials Engineering. Since 2022\, he is Associate Professor in Life Sciences and Healthcare at University of Nottingham\, Ningbo\, China. His research focuses on the characterisation of mixed biofilms using electrochemical methods and the development of novel bioprocess for efficient biosynthesis of commodity chemicals in biofilms. He collaborates with several institutions in China\, such as South China University of Technology (SCUT)\, Shenzhen Institute of Advanced Technology (SIAT) and Shanghai Institute of Materia Medica (SIMM). He has received competitive funding from Collaborative Research Programme and Marine Research Program (National Research Foundation\, Singapore)\, Public Utility Board\, Singapore\, and municipal level funding (Ningbo\, China). \n  \nDr Philip Turner \nDr Philip Turner is a senior researcher in the Infections\, Respiratory and Acute care Research Group and the Head of Operations of the HealthTech Research Centre in Community Healthcare (Oxford Health NHS Foundation Trust) based at the Nuffield Department of Primary Care Health Sciences at the University of Oxford. His research interests include the diagnosis and management of common infections and approaches to antimicrobial stewardship in community healthcare settings. Recent activities include co-leadership of the RAPTOR-C19 evaluations of point-of-care tests for SARS-CoV-2 and other respiratory viruses in community care\, trial management support for the trans-European VALUE-Dx PRUDENCE RCT of the clinical and cost-effectiveness of diagnostic interventions for RTI\, and co-investigation on the NIHR and NHSE-funded TOUCAN evaluation of novel diagnostics for acute uncomplicated UTI. \n  \n  \nDr Abigail Moore \nDr Abi Moore is a practicing GP in London and a clinical researcher in the Infections\, Respiratory and Acute Care Research Group based at the Nuffield Department of Primary Care Health Sciences at the University of Oxford. Abi has a clinical and research interest in the care of older people in care homes. Her PhD is on understanding acute functional decline and its relationship to urinary tract infections in this patient group. Abi is co-lead of the DISCO UTI study which is developing new ways to accurately diagnose UTI in care home residents\, including approaches incorporating novel diagnostic tests. \n  \n  \n  \nTo read more about Medilink Midlands’ role within the WMHTIA project\, click here. \nFor more information on the wider project\, click here to visit the WMHTIA website. \nThis event forms part of the West Midlands Health Tech Innovation Accelerator (WMHTIA) event series. Medilink Midlands are one of a consortium of delivery partners for the WMHTIA\, a project funded by the Department for Science\, Innovation and Technology\, Innovate UK and West Midlands Combined Authority (part of City Regions).
URL:https://staging.medilinkmidlands.com/event/in-person-event-design-for-health-med-tech-innovation-2/
LOCATION:Enterprise Wharf\, Innovation Birmingham\, Holt Street\, Birmingham\, B7 4BB\, United Kingdom
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Linsey Horsepool Medilink Midlands":MAILTO:events@medilinkmidlands.com
END:VEVENT
END:VCALENDAR